Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centersAndrew M. Evens, Matthew A. Lunning, Alexey V. Danilov et al.|Blood|2021Cited by 125
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMTDavid Buchbinder, Bronwen E. Shaw, Sita Bhella et al.|Bone Marrow Transplantation|2018Cited by 104
Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow TransplantationDebra Lynch Kelly, Bronwen E. Shaw, David Buchbinder et al.|Transplantation and Cellular Therapy|2017Cited by 65
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort studyAdam Zayac, Matthew A. Lunning, Andrew M. Evens et al.|Haematologica|2021Cited by 44
Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR studySeema Naik, Rammurti T. Kamble, Marcie Riches et al.|Transplant Infectious Disease|2019Cited by 27